453 related articles for article (PubMed ID: 29566264)
1. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP
Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264
[TBL] [Abstract][Full Text] [Related]
2. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis.
Kim SW; Son HS; Troya IS; Kim JY; Kim MJ; Fraser MO; Kim JH
Neurourol Urodyn; 2017 Mar; 36(3):677-682. PubMed ID: 27028369
[TBL] [Abstract][Full Text] [Related]
3. Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC).
Hoke TP; Goldstein H; Saks EK; Vakili B
Neurourol Urodyn; 2017 Mar; 36(3):784-786. PubMed ID: 27092957
[TBL] [Abstract][Full Text] [Related]
4. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
5. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
Sun Y; Fang Z; Ding Q; Zheng J
Neurourol Urodyn; 2014 Mar; 33(3):341-4. PubMed ID: 23744795
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.
Cheng C; Rosamilia A; Healey M
Int Urogynecol J; 2012 Oct; 23(10):1361-6. PubMed ID: 22398828
[TBL] [Abstract][Full Text] [Related]
7. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
[TBL] [Abstract][Full Text] [Related]
8. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year.
Glemain P; Rivière C; Lenormand L; Karam G; Bouchot O; Buzelin JM
Eur Urol; 2002 Jan; 41(1):79-84. PubMed ID: 11999471
[TBL] [Abstract][Full Text] [Related]
9. Role of cystoscopy as primary initial investigation in interstitial cystitis/bladder pain syndrome.
Singh A; Priyadarshi S; Bansal S; Nandwani S
Urologia; 2024 Feb; 91(1):189-193. PubMed ID: 37776017
[TBL] [Abstract][Full Text] [Related]
10. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis.
Jiang YH; Jhang JF; Kuo HC
PLoS One; 2016; 11(3):e0151692. PubMed ID: 26999787
[TBL] [Abstract][Full Text] [Related]
12. Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.
Plair A; Evans RJ; Langefeld CD; Matthews CA; Badlani G; Walker SJ
Urology; 2021 Dec; 158():74-80. PubMed ID: 34303757
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.
Chen Y; Ying Z; Xiao Y; Liu Y; Wu S
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():156-161. PubMed ID: 34492610
[TBL] [Abstract][Full Text] [Related]
14. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.
Schachar JS; Evans RJ; Parks GE; Zambon J; Badlani G; Walker SJ
Int Urogynecol J; 2019 Nov; 30(11):1863-1870. PubMed ID: 31254048
[TBL] [Abstract][Full Text] [Related]
15. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention?
Cole EE; Scarpero HM; Dmochowski RR
Neurourol Urodyn; 2005; 24(7):638-42. PubMed ID: 16208660
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
17. Autonomic response during bladder hydrodistention in patients with bladder pain syndrome.
Stav K; Lang E; Fanus Z; Leibovici D
J Urol; 2012 Jul; 188(1):117-21. PubMed ID: 22578723
[TBL] [Abstract][Full Text] [Related]
18. [Hydrodistention of the bladder in patients with interstitial cystitis--clinical efficacy and its association with immunohistochemical findings for bladder tissues].
Inoue R; Takahashi S; Sunaoshi K; Ichihara K; Masumori N; Tsukamoto T
Hinyokika Kiyo; 2006 Oct; 52(10):765-8. PubMed ID: 17131863
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
20. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
